China Council for the promotion of drugs investigates relevant policies of purchasing organizations of drug groups in the United States
-
Last Update: 2015-05-18
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Source: China pharmaceutical innovation promotion association may 15, 2015, song Ruilin, executive chairman of China pharmaceutical promotion association, Chen Changxiong, secretary general and Wang Xin, deputy director, visited Lek (aikai consulting) Los Angeles company to conduct research on Relevant Issues of group purchasing organization (GPO) Linde Wilson, Executive Consultant of Lek, nurry Hong, partner, Scott Lee and Jamie brown, senior managers, communicated with the delegation of the drug promotion association Both sides discussed the role, development process, operation mode, case experience and future development trend of GPO in drug supply chain Through this research activity, the drug promotion association obtained the first-hand information materials of GPO research in the United States, which will provide important support and reference for relevant pharmaceutical policy research work Group photo of representatives of both parties
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
